Anixa Biosciences ANIX
NASDAQ ANIX
$2.95 +0.18 (+6.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Price to Sales (2011 - 2023)

Updated

Anixa Biosciences' (ANIX) Price to Sales came in at 470.90 for fiscal Q4 2023 (quarter ended Oct 31, 2023), down 11.6% from the prior quarter.

Analysis

Anixa Biosciences (ANIX) Price to Sales (2011 - 2023) Analysis & Trends

For FY2023 (ended Oct 31, 2023), Anixa Biosciences' Price to Sales stood at 468.66.

  • In prior fiscal years, Anixa Biosciences' Price to Sales was 279.97 in FY2021 and 314.74 in FY2019 (+357.2%).
  • The fiscal Q4 2023 figure stands as the lowest quarterly Price to Sales since fiscal Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Anixa Biosciences 102.02 Mn 100.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2023 470.90
Jul 31, 2023 532.79
Apr 30, 2023 604.36
Oct 31, 2021 279.97
Jul 31, 2021 258.05
Apr 30, 2021 299.17
Jan 31, 2021 125.23
Oct 31, 2019 314.74
Jul 31, 2019 154.39
Apr 30, 2019 61.08
Oct 31, 2018 68.84
Jul 31, 2018 41.70
Apr 30, 2018 47.89
Oct 31, 2017 37.74
Jul 31, 2017 18.03
Oct 31, 2016 140.70
Jul 31, 2016 126.44
Oct 31, 2015 3.51
Jul 31, 2015 4.01
Apr 30, 2015 2.24
API Access

Anixa Biosciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ANIX&period=max&api_key=YOUR_API_KEY